Found 203 results
Author [ Title(Desc)] Type Year
Filters: Author is Luiz E Bermudez  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
D. Patel, Danelishvili, L., Yamazaki, Y., Alonso, M., Paustian, M. L., Bannantine, J. P., Meunier-Goddik, L., and Bermudez, L. E., The ability of Mycobacterium avium subsp. paratuberculosis to enter bovine epithelial cells is influenced by preexposure to a hyperosmolar environment and intracellular passage in bovine mammary epithelial cells., Infection and immunity, vol. 74, no. 5, pp. 2849-55, 2006.
Y. Yamazaki, Danelishvili, L., Wu, M., Hidaka, E., Katsuyama, T., Stang, B. V., Petrofsky, M., Bildfell, R. J., and Bermudez, L. E., The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells., Cellular microbiology, vol. 8, no. 5, pp. 806-14, 2006.
L. E. Bermudez and Young, L. S., Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex., Antimicrobial agents and chemotherapy, vol. 32, no. 8, pp. 1149-53, 1988.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Barbara-Burnham, L., and Young, L. S., Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice., Antimicrobial agents and chemotherapy, vol. 40, no. 3, pp. 546-51, 1996.
C. B. Inderlied, Barbara-Burnham, L., Wu, M., Young, L. S., and Bermudez, L. E., Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages., Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1838-43, 1994.
L. E. Bermudez, Kolonoski, P., Young, L. S., and Inderlied, C. B., Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection., Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1844-8, 1994.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., Aralar, P., Wu, M., and Young, L. S., Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium., Antimicrobial agents and chemotherapy, vol. 45, no. 1, pp. 217-22, 2001.
S. Daniel-Wayman, Abate, G., Barber, D. L., Bermudez, L. E., Coler, R. N., Cynamon, M. H., Daley, C. L., Davidson, R. M., Dick, T., R Floto, A., Henkle, E., Holland, S. M., Jackson, M., Lee, R. E., Nuermberger, E. L., Olivier, K. N., Ordway, D. J., D Prevots, R., Sacchettini, J. C., Salfinger, M., Sassetti, C. M., Sizemore, C. F., Winthrop, K. L., and Zelazny, A. M., Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research., Am J Respir Crit Care Med, vol. 199, no. 8, pp. 947-951, 2019.
L. Danelishvili and Bermudez, L. E., Analysis of pyroptosis in bacterial infection., Methods in molecular biology (Clifton, N.J.), vol. 1004, pp. 67-73, 2013.
H. R. C. Shoen, Rose, S. J., Ramsey, S. A., de Morais, H., and Bermudez, L. E., Analysis of Staphylococcus infections in a veterinary teaching hospital from 2012 to 2015., Comp Immunol Microbiol Infect Dis, vol. 66, p. 101332, 2019.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S., An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract., The Journal of infectious diseases, vol. 165, no. 1, pp. 75-9, 1992.
L. E. Bermudez, Parker, A., and Petrofsky, M., Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases., Clinical and experimental immunology, vol. 116, no. 1, pp. 94-9, 1999.
C
M. Petrofsky and Bermudez, L. E., CD4+ T cells but Not CD8+ or gammadelta+ lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route., Infection and immunity, vol. 73, no. 5, pp. 2621-7, 2005.
L. E. Bermudez and Sangari, F. J., Cellular and molecular mechanisms of internalization of mycobacteria by host cells., Microbes and infection / Institut Pasteur, vol. 3, no. 1, pp. 37-42, 2001.
A. Limia, Sangari, F. J., Wagner, D., and Bermudez, L. E., Characterization and expression of secA in Mycobacterium avium., FEMS microbiology letters, vol. 197, no. 2, pp. 151-7, 2001.
G. Carter, Wu, M., Drummond, D. C., and Bermudez, L. E., Characterization of biofilm formation by clinical isolates of Mycobacterium avium., Journal of medical microbiology, vol. 52, no. Pt 9, pp. 747-52, 2003.
F. J. Sangari, Bächli, M., Bermudez, L. E., and Bodmer, T., Characterization of IS666, a newly described insertion element of Mycobacterium avium., Microbial & comparative genomics, vol. 5, no. 4, pp. 181-8, 2000.
S. S. Chiplunkar, Silva, C. A., Bermudez, L. E., and Danelishvili, L., Characterization of membrane vesicles released by Mycobacterium avium in response to environment mimicking the macrophage phagosome., Future Microbiol, vol. 14, pp. 293-313, 2019.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., and Young, L. S., Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice., Antimicrobial agents and chemotherapy, vol. 38, no. 12, pp. 2717-21, 1994.
L. E. Bermudez, Petrofsky, M., Wu, M., and Young, L. S., Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice., The Journal of infectious diseases, vol. 178, no. 3, pp. 896-9, 1998.
L. E. Bermudez, Nash, K., Petrofsky, M., Young, L. S., and Inderlied, C. B., Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice., Antimicrobial agents and chemotherapy, vol. 44, no. 10, pp. 2619-22, 2000.

Pages